The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application (TM99492418) for the mark TRI-VYLIBRA LO AX. This application, filed on November 12, 2025, indicates the mark's intended use in commerce for oral contraceptives.

This filing represents an initial step in the trademark registration process. While it does not grant immediate rights, it establishes a priority date. The applicant will eventually need to demonstrate actual use in commerce to obtain a full registration. Compliance officers in the pharmaceutical sector should be aware of this filing as it pertains to a competitor's or their own company's product branding strategy.